Use of complementary and alternative medicine by patients with end-stage renal disease on haemodialysis in Trinidad: A descriptive study

被引:31
作者
Bahall, Mandreker [1 ,2 ,3 ]
机构
[1] Univ West Indies, Arthur Lok Jack Grad Sch Business, St Augustine, Trinidad Tobago
[2] Univ West Indies, Sch Med, St Augustine, Trinidad Tobago
[3] House 57,Calcutta Rd 3, Couva, Trinidad, Trinidad Tobago
来源
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE | 2017年 / 17卷
关键词
Adverse effect; Complementary and alternative medicine; Haemodialysis; Prevalence; Treatment; GINKGO-BILOBA; CARDIAC PATIENTS; CARE; CAM; POPULATION; PREVALENCE; WARFARIN; QUALITY; SAFETY; USAGE;
D O I
10.1186/s12906-017-1755-7
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Despite the paucity of scientific evidence, complementary and alternative medicine (CAM) is widely used for the prevention and treatment of illness, holistic care, and counteracting the adverse effects of conventional medicine (CM). This study investigates the use of CAM by patients with end-stage renal disease (ESRD) on haemodialysis. Methods: This quantitative study was conducted from November 1, 2014 to December 31, 2014 in the haemodialysis unit at San Fernando General Hospital (San Fernando, Trinidad). Face-to-face questionnaire-based interviews were held with 101 of 125 eligible patients (response rate, 80.5%) at the chairside during haemodialysis. The completed questionnaires were entered into a secure computer database. Data analysis included descriptive analysis,X-2 tests, and binary logistic regression analysis. Results: A minority of the patients were CAM users (n = 19; 18.8%). All 19 CAM users took medicinal herbs, 78.9% (n = 15) used spiritual therapy, and 10.5% (n = 2) used alternative systems. Medicinal tea (n = 15; 78.9%), garlic (Allium sativum) (n = 17; 73.7%), and ginger (Zingiber officinale roscoe) (n = 13; 68.4%) were the most commonly used medicinal herbs. Seven (36.8%) patients used Chinese herbal medicines and 3 (15.8%) patients used Aloe vera. All CAM users were willing to use CAM without supervision or monitoring by their doctors while receiving CM. The use of CAM could not be predicted by age, sex, ethnicity, education, religion, marital status, or employment. Nearly all (98%) patients were satisfied with CAM. More than one-third (36.8%) of patients did not disclose their use of CAM to their doctors, who were generally indifferent to such therapy. Conclusions: The use of CAM by patients with ESRD was relatively infrequent. All patients used medicinal herbs, most patients used spiritual therapy, and a minority of patients used alternative systems. Complementary and alternative medicine was primarily used for spiritual reasons and the likelihood of its use was influenced by family, friends, and other patients. Patients continued using CM with one or more CAM therapies without informing their healthcare providers, which is a major health risk.
引用
收藏
页数:10
相关论文
共 50 条
[21]   The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis [J].
Kayikcioglu, Meral ;
Tumuklu, Murat ;
Ozkahya, Mehmet ;
Ozdogan, Oner ;
Asci, Gulay ;
Duman, Soner ;
Toz, Huseyin ;
Can, Levent H. ;
Basci, Ali ;
Ok, Ercan .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (03) :956-962
[22]   Complementary and alternative medicine usage among cardiac patients: a descriptive study [J].
Mandreker Bahall .
BMC Complementary and Alternative Medicine, 15
[23]   The trends of complementary alternative medicine use among cancer patients [J].
Jazieh, Abdul Rahman ;
Abuelgasim, Khadega A. ;
Ardah, Husam, I ;
Alkaiyat, Mohammad ;
Da'ar, Omar B. .
BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2021, 21 (01)
[24]   YKL-40 in patients with end-stage renal disease receiving haemodialysis [J].
Nielsen, Ture Lange ;
Plesner, Louis Lind ;
Warming, Peder Emil ;
Pallisgaard, Jannik Langtved ;
Dalsgaard, Morten ;
Schou, Morten ;
Host, Ulla ;
Rydahl, Casper ;
Brandi, Lisbet ;
Kober, Lars ;
Johansen, Julia Sidenius ;
Kastrup, Jens ;
Iversen, Kasper Karmark .
BIOMARKERS, 2018, 23 (04) :357-363
[25]   A breath ammonia analyser for monitoring patients with end-stage renal disease on haemodialysis [J].
Limeres, J. ;
Garcez, J. F. ;
Marinho, J. S. ;
Loureiro, A. ;
Diniz, M. ;
Diz, P. .
BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2017, 74 (01) :24-29
[26]   Haemodialysis impairs clopidogrel but not aspirin responsiveness in patients with end-stage renal disease [J].
Htun, Patrik ;
Kan, Tatiana ;
Mueller, Eda ;
Pohle, Cosima ;
Schindler, Ralf ;
Geisler, Tobias ;
Gawaz, Meinrad ;
Bocksch, Wolfgang ;
Fateh-Moghadam, Suzanne .
THROMBOSIS AND HAEMOSTASIS, 2014, 111 (04) :662-669
[27]   Molecular characterization and genotyping of hepatitis C virus from Sudanese end-stage renal disease patients on haemodialysis [J].
Zitha, Trodia ;
Chen, Chien-Yu ;
Mudawi, Hatim ;
Hussein, Waleed ;
Mukhtar, Maowia ;
Shigidi, Mazin ;
Yousif, Mohamed Elamin Awad ;
Ali, Mohammed Ahmed ;
Glebe, Dieter ;
Kramvis, Anna .
BMC INFECTIOUS DISEASES, 2022, 22 (01)
[28]   Restless legs syndrome in end stage renal disease patients on haemodialysis [J].
Haider, Irfan ;
Anees, Muhammad ;
Shahid, Syed Adnan Hussain .
PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2014, 30 (06) :1209-1212
[29]   The Epidemiology of End Stage Renal Disease at a Centre in Trinidad [J].
Mungrue, K. ;
Ramdial, S. ;
Barran, A. ;
Lorinda, B. ;
Bridgelal, A. ;
Gildharie, S. ;
LeeLoy, J. ;
Mohammed, O. ;
Ragbir, T. ;
Rampersad, R. ;
Ramtahal, R. ;
Suratsingh, N. .
WEST INDIAN MEDICAL JOURNAL, 2011, 60 (05) :553-556
[30]   Patterns of Complementary and Alternative Medicine Use in Saudi Arabian Patients With Inflammatory Bowel Disease: A Cross-Sectional Study [J].
Altunisi, Albaraa, Jr. ;
Mosli, Mahmoud ;
Banweer, Mazen ;
Qari, Yousif ;
Arif, Faris O. ;
Saadah, Omar, I .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)